Log in to save to my catalogue

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kid...

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kid...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_156228

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

About this item

Full title

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2011-06, Vol.377 (9784), p.2181-2192

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Summary Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary revascularisation in people without kidney disease, but its effects in people with moderate-to-severe kidney disease are uncertain. The SHARP trial aimed to assess the efficacy and safety of the com...

Alternative Titles

Full title

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_156228

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_156228

Other Identifiers

ISSN

0140-6736,1474-547X

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(11)60739-3